| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10070627 | European Journal of Surgical Oncology (EJSO) | 2005 | 6 Pages |
Abstract
The diagnostic rate of CA19-9 in pancreatic cancer is better than that of CEA and CA242. Combined detection of CEA and CA242 can improve the diagnostic specificity obviously. High levels of serum markers are associated with advanced stage of the disease. Patients with two or three markers positive expression of CEA, CA19-9, and CA242 simultaneously had a shorter survival time.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
X.G. Ni, X.F. Bai, Y.L. Mao, Y.F. Shao, J.X. Wu, Y. Shan, C.F. Wang, J. Wang, Y.T. Tian, Q. Liu, D.K. Xu, P. Zhao,